Hyperthyroid heart disease

The heart is an organ sensitive to the action of thyroid hormone, and measurable changes in cardiac performance are detected with small variations in thyroid hormone serum concentrations. Most patients with hyperthyroidism experience cardiovascular manifestations, and the most serious complications of hyperthyroidism occur as a result of cardiac involvement. Recent studies provide important insights into the molecular pathways that mediate the action of thyroid hormone on the heart and allow a better understanding of the mechanisms that underlie the hemodynamic and clinical manifestations of hyperthyroidism. Several cardiovascular conditions and drugs can interfere with thyroid hormone levels and may pose a difficulty in interpretation of laboratory data in patients with suspected thyroid heart disease. The focus of this report is a review of the current knowledge of thyroid hormone action on the heart and the clinical and hemodynamic laboratory findings as well as therapeutic management of patients with hyperthyroid heart disease.

[1]  I. Klein,et al.  Thyrotoxicosis and the heart. , 1998, Endocrinology and metabolism clinics of North America.

[2]  F. Sellke,et al.  The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.

[3]  S. Liggett,et al.  Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. , 1997, Circulation.

[4]  K. Mann,et al.  Influence of coronary artery bypass surgery on thyroid hormone parameters. , 1997, Hormone research.

[5]  J. Forfar.  Atrial fibrillation and the pituitary-thyroid axis: a re-evaluation. , 1997, Heart.

[6]  I. Klein,et al.  Acute effects of thyroid hormone on vascular smooth muscle. , 1996, Thyroid : official journal of the American Thyroid Association.

[7]  I. Olivotto,et al.  Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism. , 1996, The American journal of cardiology.

[8]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[9]  F. Spinale,et al.  The direct effects of 3,5,3'-triiodo-L-thyronine (T3) on myocyte contractile processes. Insights into mechanisms of action. , 1995, The Journal of thoracic and cardiovascular surgery.

[10]  R. Fletterick,et al.  The Molecular Biology of Thyroid Hormone Action , 1995, Annals of the New York Academy of Sciences.

[11]  B. Kantharia,et al.  Reversible dilated cardiomyopathy: an unusual case of thyrotoxicosis. , 1995, American heart journal.

[12]  B. O’Malley,et al.  Mechanisms for synergistic activation of thyroid hormone receptor and retinoid X receptor on different response elements. , 1994, The Journal of biological chemistry.

[13]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[14]  G S Levey,et al.  Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.

[15]  I. Saito,et al.  Hypertension in thyroid disorders. , 1994, Endocrinology and metabolism clinics of North America.

[16]  R. Solaro,et al.  Differential regulation of slow-skeletal and cardiac troponin I mRNA during development and by thyroid hormone in rat heart. , 1994, Journal of molecular and cellular cardiology.

[17]  Á. Zarain-Herzberg,et al.  Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco (endo) plasmic reticulum Ca(2+)-ATPase gene. , 1994, The Journal of biological chemistry.

[18]  C. Baumgarten,et al.  Bursting of cardiac sodium channels after acute exposure to 3,5,3'-triiodo-L-thyronine. , 1993, Circulation research.

[19]  E. Morkin.  Regulation of Myosin Heavy Chain Genes in the Heart , 1993, Circulation.

[20]  J. Hershman,et al.  β-Adrenergic blockade for the treatment of hyperthyroidism , 1992 .

[21]  S. Bahouth.  Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. , 1991, The Journal of biological chemistry.

[22]  I. Klein,et al.  Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. , 1991, The Journal of clinical endocrinology and metabolism.

[23]  P. Brugada,et al.  Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. , 1990, Journal of the American College of Cardiology.

[24]  W. Isley,et al.  Use of esmolol in managing a thyrotoxic patient needing emergency surgery. , 1990, The American journal of medicine.

[25]  J. Funder,et al.  Altered thyroidal status and the in vivo synthesis of atrial natriuretic peptide in the rat heart , 1990, Molecular and Cellular Endocrinology.

[26]  J. Lingrel,et al.  Thyroid and glucocorticoid hormones regulate the expression of multiple Na,K-ATPase genes in cultured neonatal rat cardiac myocytes. , 1990, The Journal of biological chemistry.

[27]  F I Gilbert,et al.  Graves' Disease: Influence of Age on Clinical Findings , 1988 .

[28]  T. Gustafson,et al.  Thyroid hormone regulates expression of a transfected alpha-myosin heavy-chain fusion gene in fetal heart cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Brunton,et al.  Increased myocardial beta-receptors and adrenergic responses in hyperthyroid pigs. , 1987, The American journal of physiology.

[30]  I. Klein,et al.  Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. , 1986, The Journal of clinical investigation.

[31]  B. Nadal-Ginard,et al.  All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. , 1986, Science.

[32]  Y. Gilboa,et al.  Mitral valve prolapse in hyperthyroidism of two different origins. , 1985, British heart journal.

[33]  G. Beckett,et al.  A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotrophin releasing hormone test? , 1984, British medical journal.

[34]  D. Solomon,et al.  A study of cardiac effects of thyroid hormones: evidence for amelioration of the effects of thyroxine by sodium ipodate. , 1984, Endocrinology.

[35]  A. Toft,et al.  Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.

[36]  K. Ito,et al.  Management of atrial fibrillation in the post-thyrotoxic state. , 1982, The American journal of medicine.

[37]  J. Laragh,et al.  PLasma renin activity in syndromes of thyroid hormone excess and deficiency. , 1982, Life sciences.

[38]  J. Spann,et al.  Hyperthyroidism and mitral-valve prolapse. , 1981, The New England journal of medicine.

[39]  P. Passa,et al.  Left ventricular function and hyperthyroidism. , 1981, British heart journal.

[40]  G. Shenfield,et al.  Influence of Thyroid Dysfunction on Drug Pharmacokinetics , 1981, Clinical pharmacokinetics.

[41]  W. D. Mason,et al.  Propranolol for thyroid storm. , 1977, The New England journal of medicine.

[42]  T. Gross,et al.  Tests for maturity of fetal lung. , 1977, The New England journal of medicine.

[43]  S. Fujii,et al.  Serum Dopamine-β-hydroxylase Activity in Thyroid Disorders , 1974 .

[44]  W. Degroot,et al.  Hyperthyroidism as a high cardiac output state. , 1970, American heart journal.

[45]  S. Epstein,et al.  Influence of hyperthyroidism on the effects of norepinephrine on myocardial adenyl cyclase activity and contractile state. , 1969, Endocrinology.

[46]  E. Braunwald,et al.  STUDIES ON DIGITALIS. VIII. EFFECT OF AUTONOMIC INNERVATION AND OF MYOCARDIAL CATECHOLAMINE STORES UPON THE CARDIAC ACTION OF OUABAIN , 1963 .

[47]  G. Sandler,et al.  The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. , 1959, The Quarterly journal of medicine.

[48]  J. Means,et al.  Cardiovascular symptomatology in exophthalmic goiter , 1932 .

[49]  E. Marqusee,et al.  Subclinical thyrotoxicosis. , 1998, Endocrinology and metabolism clinics of North America.

[50]  K. Harjai,et al.  Effects of Amiodarone on Thyroid Function , 1997, Annals of Internal Medicine.

[51]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[52]  J. Hershman,et al.  Beta-adrenergic blockade for the treatment of hyperthyroidism. , 1992, The American journal of medicine.

[53]  L. Leinwand,et al.  Thyroid hormone regulates expression of a transfected human alpha-myosin heavy-chain fusion gene in fetal rat heart cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Aizawa,et al.  Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. , 1989, Cardiology.

[55]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[56]  F. Ismail-Beigi,et al.  Effect of thyroid hormone on the abundance of Na,K-adenosine triphosphatase alpha-subunit messenger ribonucleic acid. , 1987, Molecular endocrinology.

[57]  F. Ismail-Beigi,et al.  Effect of Thyroid Hormone on the Abundance of Na, K-Adenosine Triphosphatase α-Subunit Messenger Ribonucleic Acid* , 1987 .

[58]  J. Lanfranchi,et al.  [Absence of ultra-structural histological lesions of the myocardium in cardiac insufficiency of hyperthyroidism]. , 1986, Annales de medecine interne.

[59]  H. Ikram.  The nature and prognosis of thyrotoxic heart disease. , 1985, The Quarterly journal of medicine.

[60]  S. Fujii,et al.  Serum dopamine-beta-hydroxylase activity in thyroid disorders. , 1974, The Journal of clinical endocrinology and metabolism.

[61]  S. Waldstein.  Thyroid-catecholamine interrelations. , 1966, Annual review of medicine.

[62]  A. Thomsen,et al.  Determination of cardiac output and other hemodynamic data in patients with hyper- and hypothyrodism, using dye dilution technique. , 1960, Scandinavian journal of clinical and laboratory investigation.

[63]  J. G. Gibson,et al.  CLINICAL STUDIES OF THE BLOOD VOLUME. V. HYPERTHYROIDISM AND MYXEDEMA. , 1939, The Journal of clinical investigation.